Literature DB >> 25593319

Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance.

Ashley S Williams1, Li Kang2, Jenny Zheng2, Carrie Grueter3, Deanna P Bracy2, Freyja D James2, Ambra Pozzi4, David H Wasserman5.   

Abstract

Hepatic insulin resistance is associated with increased collagen. Integrin α1β1 is a collagen-binding receptor expressed on hepatocytes. Here, we show that expression of the α1 subunit is increased in hepatocytes isolated from high fat (HF)-fed mice. To determine whether the integrin α1 subunit protects against impairments in hepatic glucose metabolism, we analyzed glucose tolerance and insulin sensitivity in HF-fed integrin α1-null (itga1(-/-)) and wild-type (itga1(+/+)) littermates. Using the insulin clamp, we found that insulin-stimulated hepatic glucose production was suppressed by ∼50% in HF-fed itga1(+/+) mice. In contrast, it was not suppressed in HF-fed itga1(-/-) mice, indicating severe hepatic insulin resistance. This was associated with decreased hepatic insulin signaling in HF-fed itga1(-/-) mice. Interestingly, hepatic triglyceride and diglyceride contents were normalized to chow-fed levels in HF-fed itga1(-/-) mice. This indicates that hepatic steatosis is dissociated from insulin resistance in HF-fed itga1(-/-) mice. The decrease in hepatic lipid accumulation in HF-fed itga1(-/-) mice was associated with altered free fatty acid metabolism. These studies establish a role for integrin signaling in facilitating hepatic insulin action while promoting lipid accumulation in mice challenged with a HF diet.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Extracellular Matrix; Insulin Resistance; Integrin; Lipid Metabolism; Liver Metabolism

Mesh:

Substances:

Year:  2015        PMID: 25593319      PMCID: PMC4358288          DOI: 10.1074/jbc.M114.615716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Long-term caloric restriction abrogates the age-related decline in skeletal muscle aerobic function.

Authors:  Russell T Hepple; David J Baker; Jan J Kaczor; Daniel J Krause
Journal:  FASEB J       Date:  2005-06-14       Impact factor: 5.191

2.  Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP.

Authors:  Elina Mattila; Teijo Pellinen; Jonna Nevo; Karoliina Vuoriluoto; Antti Arjonen; Johanna Ivaska
Journal:  Nat Cell Biol       Date:  2004-12-12       Impact factor: 28.824

3.  Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation.

Authors:  Xiwu Chen; Tristin D Abair; Maria R Ibanez; Yan Su; Mark R Frey; Rebecca S Dise; D Brent Polk; Amar B Singh; Raymond C Harris; Roy Zent; Ambra Pozzi
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

4.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

Authors:  Kanji Yamaguchi; Liu Yang; Shannon McCall; Jiawen Huang; Xing Xian Yu; Sanjay K Pandey; Sanjay Bhanot; Brett P Monia; Yin-Xiong Li; Anna Mae Diehl
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

5.  In vivo inhibition of focal adhesion kinase causes insulin resistance.

Authors:  Bharti Bisht; K Srinivasan; Chinmoy S Dey
Journal:  J Physiol       Date:  2008-06-26       Impact factor: 5.182

6.  A lipidomic analysis of nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Rebecca A Baillie; Michelle M Wiest; Faridoddin Mirshahi; Jayanta Choudhury; Onpan Cheung; Carol Sargeant; Melissa J Contos; Arun J Sanyal
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

7.  Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.

Authors:  Mara Monetti; Malin C Levin; Matthew J Watt; Mini P Sajan; Stephen Marmor; Brian K Hubbard; Robert D Stevens; James R Bain; Christopher B Newgard; Robert V Farese; Andrea L Hevener; Robert V Farese
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

8.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Toyonori Kato; Ayaka Atsumi; Takashi Yamamoto; Noriyuki Inoue; Mayumi Ishikawa; Sumiyo Okada; Naomi Ishigaki; Hitoshi Iwasaki; Yuko Iwasaki; Tadayoshi Karasawa; Shin Kumadaki; Toshiyuki Matsui; Motohiro Sekiya; Ken Ohashi; Alyssa H Hasty; Yoshimi Nakagawa; Akimitsu Takahashi; Hiroaki Suzuki; Sigeru Yatoh; Hirohito Sone; Hideo Toyoshima; Jun-ichi Osuga; Nobuhiro Yamada
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

Review 9.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.

Authors:  Catherine Postic; Jean Girard
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2.

Authors:  Kaz Jaskiewicz; Robert Rzepko; Zbigniew Sledzinski
Journal:  Dig Dis Sci       Date:  2007-09-12       Impact factor: 3.199

View more
  15 in total

Review 1.  The Vasculature in Prediabetes.

Authors:  David H Wasserman; Thomas J Wang; Nancy J Brown
Journal:  Circ Res       Date:  2018-04-13       Impact factor: 17.367

Review 2.  Insulin action and resistance in obesity and type 2 diabetes.

Authors:  Michael P Czech
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

Review 3.  The extracellular matrix and insulin resistance.

Authors:  Ashley S Williams; Li Kang; David H Wasserman
Journal:  Trends Endocrinol Metab       Date:  2015-06-06       Impact factor: 12.015

4.  Cytoophidia coupling adipose architecture and metabolism.

Authors:  Jingnan Liu; Yuanbing Zhang; Youfang Zhou; Qiao-Qi Wang; Kang Ding; Suwen Zhao; Pengfei Lu; Ji-Long Liu
Journal:  Cell Mol Life Sci       Date:  2022-10-01       Impact factor: 9.207

5.  Influence of the integrin alpha-1 subunit and its relationship with high-fat diet upon extracellular matrix synthesis in skeletal muscle and tendon.

Authors:  Monika L Bayer; Rene B Svensson; Peter Schjerling; Ashley S Williams; David H Wasserman; Michael Kjaer
Journal:  Cell Tissue Res       Date:  2020-02-28       Impact factor: 5.249

6.  Hepatic Dysfunction Caused by Consumption of a High-Fat Diet.

Authors:  Anthony R Soltis; Norman J Kennedy; Xiaofeng Xin; Feng Zhou; Scott B Ficarro; Yoon Sing Yap; Bryan J Matthews; Douglas A Lauffenburger; Forest M White; Jarrod A Marto; Roger J Davis; Ernest Fraenkel
Journal:  Cell Rep       Date:  2017-12-12       Impact factor: 9.423

7.  Autoregulation of insulin receptor signaling through MFGE8 and the αvβ5 integrin.

Authors:  Ritwik Datta; Carlos O Lizama; Amin K Soltani; William Mckleroy; Michael J Podolsky; Christopher D Yang; Tony L Huynh; Kelly M Cautivo; Biao Wang; Suneil K Koliwad; Nada A Abumrad; Kamran Atabai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

Review 8.  Integrin Linked Kinase (ILK) and its Role in Liver Pathobiology.

Authors:  Nicole Martucci; George K Michalopoulos; Wendy M Mars
Journal:  Gene Expr       Date:  2021-01-22

9.  Reversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis.

Authors:  Greg M Kowalski; Steven Hamley; Ahrathy Selathurai; Joachim Kloehn; David P De Souza; Sean O'Callaghan; Brunda Nijagal; Dedreia L Tull; Malcolm J McConville; Clinton R Bruce
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

10.  Integrin-Linked Kinase in Muscle Is Necessary for the Development of Insulin Resistance in Diet-Induced Obese Mice.

Authors:  Li Kang; Shilpa Mokshagundam; Bradley Reuter; Daniel S Lark; Claire C Sneddon; Chandani Hennayake; Ashley S Williams; Deanna P Bracy; Freyja D James; Ambra Pozzi; Roy Zent; David H Wasserman
Journal:  Diabetes       Date:  2016-04-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.